scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "Dyal, Robert A."

1 - 10 of 66 results for
 "Dyal, Robert A."
Results per page:

Rivaroxaban for Prevention of Covert Brain Infarcts and Cognitive Decline: The COMPASS MRI Substudy.

Publication Type: Academic Journal

Source(s): Stroke (00392499); Oct2020, Vol. 51 Issue 10, p2901-2909, 9p

Appendicitis risk prediction models in children presenting with right iliac fossa pain (RIFT study): a prospective, multicentre validation study

Publication Type: Periodical

Source(s): The Lancet Child & Adolescent Health; April 2020, Vol. 4 Issue: 4 p271-280, 10p

Abstract: Acute appendicitis is the most common surgical emergency in children. Differentiation of acute appendicitis from conditions that do not require operative management can be challenging in children. This study aimed to identify the optimum risk predictio...

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Publication Type: Periodical

Source(s): The Lancet; July 2019, Vol. 394 Issue: 10193 p131-138, 8p

Abstract: Two glucagon-like peptide-1 (GLP-1) receptor agonists reduced renal outcomes in people with type 2 diabetes at risk for cardiovascular disease. We assessed the long-term effect of the GLP-1 receptor agonist dulaglutide on renal outcomes in an explorato...

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Publication Type: Periodical

Source(s): The Lancet; July 2019, Vol. 394 Issue: 10193 p121-130, 10p

Abstract: Three different glucagon-like peptide-1 (GLP-1) receptor agonists reduce cardiovascular outcomes in people with type 2 diabetes at high cardiovascular risk with high glycated haemoglobin A1c(HbA1c) concentrations. We assessed the effect of the GLP-1 re...

The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial

Publication Type: Periodical

Source(s): The Lancet Diabetes & Endocrinology; February 2020, Vol. 8 Issue: 2 p106-114, 9p

Abstract: Cardiovascular outcome trials have suggested that glucagon-like peptide 1 (GLP-1) receptor agonists might reduce strokes. We analysed the effect of dulaglutide on stroke within the researching cardiovascular events with a weekly incretin in diabetes (R...

Association Between Low-Dose Rivaroxaban With or Without Aspirin and Ischemic Stroke Subtypes: A Secondary Analysis of the COMPASS Trial

Publication Type: Periodical

Source(s): JAMA Neurology; January 2020, Vol. 77 Issue: 1 p43-48, 6p

Abstract: IMPORTANCE: The COMPASS (Cardiovascular Outcomes for People Using Anticoagulation Strategies) randomized clinical trial was stopped early owing to the efficacy of low-dose rivaroxaban plus aspirin in preventing major cardiovascular events. The main rea...

A genomic survey of the fish parasite Spironucleus salmonicida indicates genomic plasticity among diplomonads and significant lateral gene transfer in eukaryote genome evolution

Publication Type: Academic Journal

Source(s): BMC Genomics, Vol 8, Iss 1, p 51 (2007)

Abstract: Abstract Background Comparative genomic studies of the mitochondrion-lacking protist group Diplomonadida (diplomonads) has been lacking, although Giardia lamblia has been intensively studied. We have performed a sequence survey project resulting in 234...

Differences in Sensory Pain, Expectation, and Satisfaction Reported by Outpatients with Cancer or Sickle Cell Disease.

Publication Type: Academic Journal

Source(s): Pain Management Nursing; Aug2018, Vol. 19 Issue 4, p322-332, 11p

Abstract: Copyright of Pain Management Nursing is the property of W B Saunders and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, o...

sponsored